Bhatnagar, A., Marin, M. P., Lischalk, J. W., Koh, M. J., Agazzi, S., Suy, S., Harris, B. T., Sharma, S. T., Aulisi, E., Anaizi, A., Khattab, M. H., Jean, W. C., Collins, S. P., & Collins, B. T. (2025). Fractionated robotic radiosurgery for unfavorable nonfunctioning pituitary macroadenoma: 5-year outcomes from a single institution protocol. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1519445

Sisti, J. A., Delgardo, M. W., Yoh, N., Okolo, O. B., Upadhyayula, P. S., Pascual-Leone, A., Paccione, C. R., Wang, T. J. C., & Sisti, M. B. (2025). A 25-Year Update on the Facial Nerve Sparing Approach for Vestibular Schwannoma. World Neurosurgery, 195, 123603. https://doi.org/10.1016/j.wneu.2024.123603

Hébert, J., De Santis, R. J., Daniyal, L., Mannan, S., Ng, E., Thain, E., Sanabria-Salas, M. C., Kim, R. H., Bril, V., & Reid, A. Y. (2024). Epilepsy in neurofibromatosis type 1: Prevalence, phenotype, and genotype in adults. Epilepsy Research, 202, 107336. https://doi.org/10.1016/j.eplepsyres.2024.107336

Arrillaga-Romany, I., Gardner, S. L., Odia, Y., Aguilera, D., Allen, J. E., Batchelor, T., Butowski, N., Chen, C., Cloughesy, T., Cluster, A., de Groot, J., Dixit, K. S., Graber, J. J., Haggiagi, A. M., Harrison, R. A., Kheradpour, A., Kilburn, L. B., Kurz, S. C., Lu, G., … Wen, P. Y. (2024). ONC201 (Dordaviprone) in Recurrent H3 K27M–Mutant Diffuse Midline Glioma. Journal of Clinical Oncology, 42(13), 1542–1552. https://doi.org/10.1200/jco.23.01134

Guo, Y., Valk, J. E., Fecher, R., O’Toole, K., Saqi, A., & Sonett, J. (2023). Case of Metastatic Atypical Meningioma to Lung: Utility of Cytological Preparations for Intraoperative Diagnosis. American Journal of Clinical Pathology, 160(Supplement_1), S104–S104. https://doi.org/10.1093/ajcp/aqad150.228

Jain, V., Policeni, B., Juliano, A. F., Adunka, O., Agarwal, M., Dubey, P., Friedman, E. R., Gule-Monroe, M. K., Hagiwara, M., Hunt, C. H., Lo, B. M., Oh, E. S., Rath, T. J., Roberts, J. K., Schultz, D., Taheri, M. R., Zander, D., & Burns, J. (2023). ACR Appropriateness Criteria® Tinnitus: 2023 Update. Journal of the American College of Radiology, 20(11), S574–S591. https://doi.org/10.1016/j.jacr.2023.08.017

Sedor, G. J., Lee, A. W., Gallitto, M., Pasetsky, J., Helis, C. A., Chan, M. D., Beckham, T., McGovern, S. L., & Wang, T. J. C. (2023). Multi-Institutional Study of Stereotactic Radiosurgery for Recurrent WHO Grade 2/3 Meningiomas: An Interim Analysis. International Journal of Radiation Oncology*Biology*Physics, 117(2), e148. https://doi.org/10.1016/j.ijrobp.2023.06.965

Rodriguez, J., Martinez, G., Mahase, S., Roytman, M., Haghdel, A., Kim, S., Madera, G., Magge, R., Pan, P., Ramakrishna, R., Schwartz, T. H., Pannullo, S. C., Osborne, J. R., Lin, E., Knisely, J. P. S., Sanelli, P. C., & Ivanidze, J. (2023). Cost-Effectiveness Analysis of68Ga-DOTATATE PET/MRI in Radiotherapy Planning in Patients with Intermediate-Risk Meningioma. American Journal of Neuroradiology, 44(7), 783–791. https://doi.org/10.3174/ajnr.a7901

Vize, C. J., Kim, S. K., Matthews, T., Macsai, M., Merrell, R., Hsu, S., Kundu, M. G., Yoon, J., Kennedy, E., Pai, M., Bain, E., Lassman, A. B., & Moazami, G. (2023). A Phase 3b Study for Management of Ocular Side Effects in Patients with Epidermal Growth Factor Receptor-Amplified Glioblastoma Receiving Depatuxizumab Mafodotin. Ophthalmic Research, 1030–1043. Portico. https://doi.org/10.1159/000531142

Cocito, C., Martin, B., Giantini-Larsen, A. M., Valcarce-Aspegren, M., Souweidane, M. M., Szalontay, L., Dahmane, N., & Greenfield, J. P. (2023). Leptomeningeal dissemination in pediatric brain tumors. Neoplasia, 39, 100898. https://doi.org/10.1016/j.neo.2023.100898

Parikh, P., Abdallah, H. M., Patel, A., Shariff, R. K., Nowicki, K. W., Mallela, A. N., Tonetti, D. A., Sekula, R. F., Lunsford, L. D., & Abou-Al-Shaar, H. (2023). Bibliometric Analysis of the Top 100 Cited Articles on Stereotactic Radiosurgery for Trigeminal Neuralgia. Asian Journal of Neurosurgery, 18(01), 101–107. CLOCKSS. https://doi.org/10.1055/s-0043-1761240

Jia, L., Buss, E. J., Padilla, O., & Wang, T. J. C. (2022). Prospectively Observed Histopathologic Predictors of Progression after Stereotactic Radiosurgery for Recurrent Atypical Meningioma. International Journal of Radiation Oncology*Biology*Physics, 114(3), e43–e44. https://doi.org/10.1016/j.ijrobp.2022.07.770

Yuen, C., Pan, P., Teasley, D., Miller, M., Sun, Y., Canoll, P., Joanta-Gomez, A., Bargo, A., & Iwamoto, F. (2022). PATH-32. CONCORDANCE FOR CDKN2A/B LOSS AND TERT MUTATION IN WHO 2021 CLASSIFICATION GRADE 3 MENINGIOMAS: A RETROSPECTIVE STUDY. Neuro-Oncology, 24(Supplement_7), vii157–vii157. https://doi.org/10.1093/neuonc/noac209.605

Tooley, A. A., Kim, M., Tran, A. Q., Kazim, M., & Gudis, D. A. (2022). Adjunctive Middle Turbinectomy for Endoscopic Medial Orbital Wall – Thyroid Eye Disease Decompression. International Archives of Otorhinolaryngology, 26(04), e579–e584. CLOCKSS. https://doi.org/10.1055/s-0041-1740156

Roytman, M., Kim, S., Glynn, S., Thomas, C., Lin, E., Feltus, W., Magge, R. S., Liechty, B., Schwartz, T. H., Ramakrishna, R., Karakatsanis, N. A., Pannullo, S. C., Osborne, J. R., Knisely, J. P. S., & Ivanidze, J. (2022). PET/MR Imaging of Somatostatin Receptor Expression and Tumor Vascularity in Meningioma: Implications for Pathophysiology and Tumor Outcomes. Frontiers in Oncology, 11. https://doi.org/10.3389/fonc.2021.820287

Kumthekar, P., Grimm, S. A., Aleman, R. T., Chamberlain, M. C., Schiff, D., Wen, P. Y., Iwamoto, F. M., Gursel, D. B., Reardon, D. A., Purow, B., Kocherginski, M., Helenowski, I., & Raizer, J. J. (2022). A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma. Neuro-Oncology Advances, 4(1). https://doi.org/10.1093/noajnl/vdac123